Evaluation of Hemostasis in Bleeding and Thrombotic Disorders
Part of paid clinical trials in Houston, Texas.
- Sponsor
- The University of Texas Health Science Center, Houston
- Study ID
- NCT00178594
- Status
- Recruiting
Conditions
- Blood Coagulation Disorders, Inherited
- Thrombotic Disorder
Eligibility Criteria
- Sex
- ALL
- Age
- 1 Day - 98 Years
- Healthy Volunteers
- Not accepted
Study Details
The objective of this study will be to assess the coagulation system in-vitro in a variety of bleeding and clotting disorders using the ROTEG analyzer and the thrombin generation assay.
Key Dates
- Start date
- Oct 31, 2002
- Status verified
- Dec 2024
- Primary completion
- Jan 31, 2028
- Completion
- Jan 31, 2028
Study Design
- Enrollment
- 1,000 participants (estimated)
Primary Outcome Measure
Assess primary and secondary hemostasis in individuals with bleeding and clotting disorders [ Time Frame: 24 hours ]
Central Contacts
- Katherine Addy, RN, BSN, MPH713-500-8352
- Daisy Garcia, RN, BSN713-500-8386
Locations (2)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| The Univerisity of Texas Health Science Center at Houston | Houston | Texas | 77030 | Miguel Escobar, MD |
| UT Physicians Women's Center-Texas Medical Center | Houston | Texas | 77030 | Randa Jalloul, MD |